Latest Headlines
-
SK pharmteco Boosts Domestic Peptide Scale-Up With Investment In California Facility
10/23/2025
This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing.
-
Upperton Expands High Precision Filling Capability At Nottingham Facility
10/22/2025
The system has been installed at Upperton’s state-of-the-art 60,000-square-foot GMP facility. The site supports formulation development and clinical manufacturing across a broad range of dosage forms, including oral solids, nasal, pulmonary and parenteral.
-
Cambrex Unveils $120 Million Investment To Expand API Manufacturing And Strengthen U.S. Drug Supply Resilience
10/22/2025
Cambrex, a leading global CDMO, is addressing increased demand for API development and manufacturing and accelerating the company’s leadership role in the fast-growing peptide therapeutics market.
-
Merck Announces Plans For $3 Billion Small Molecule Drug Manufacturing Expansion In Virginia
10/22/2025
Governor Glenn Youngkin announced today that Merck, known as MSD outside of the United States and Canada, is starting construction on a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility that will serve as Merck’s Center of Excellence for Pharmaceutical Ingredients and Small Molecule Manufacturing, and generate 500 jobs at its Elkton, Virginia, site. Merck’s announcement reflects a significant increase beyond the original scope of a $2 billion investment and 300 jobs. The expansion is part of Merck’s $70 billion commitment to domestic research, development, and capital projects.
-
Comecer To Exhibit Aseptic Filling Solutions At ISPE Annual Meeting 2025
10/17/2025
Comecer will be exhibiting at the ISPE Annual Meeting & Expo 2025, on October 26 - 29 at the Charlotte Convention Center in North Carolina, USA.
- 3P Innovation's Fill2Weight Technology Expands High-Precision Filling Capability At The CDMO, Upperton 10/16/2025
-
Ensera Launches As New Brand Identity For SteriPack
10/14/2025
New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.
-
Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US
10/14/2025
Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.
-
Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
10/14/2025
Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO), today announced a strategic partnership to deliver fully integrated early phase clinical trial solutions.
-
Ypsomed Investing $195M Into Holly Springs, NC Drug Manufacturing Facility
10/10/2025
Ypsomed announced plans Oct. 9 to invest $195.4M in Holly Springs for its first North American manufacturing facility. The company will purchase and customize an existing 110,000-square-foot building in the YIELD Holly Springs. This purpose-built manufacturing campus is part of the broader Holly Springs Business Park, located just off N.C. 55. Ypsomed has committed to creating 62 high-quality jobs.